Figure 3.

Effect of (A) cyclopamine, (B) gefitinib and (C) lapatinib on growth of androgen-independent prostate cancer cells.

Shaw and Prowse Cancer Cell International 2008 8:3   doi:10.1186/1475-2867-8-3
Download authors' original image